NewsRoom Articles - Page 244 of 624

TuesdayNov 30, 2021 4:20 am

420 with CNW — Should Alcohol Sellers Worry about Competition from Cannabis-Infused Drinks?

Marijuana products are legally available in Guam, Washington, DC, and 19 other states. In states where recreational marijuana is legal, THC-infused drinks such as Hi5, Kalo, Keef, Cann and Wunder are marketed alongside other drinks, including wine and beer. Today, we look at whether producers of alcoholic beverages should worry about competition from cannabis-infused drinks. Colleen McClellan of Datassential says that we are likely to see an increase in the use and interest in cannabis-infused drinks as more states relax their regulations on the herb. McClellan, who is the regional director of the leading food and beverage insights platform, noted…

MondayNov 29, 2021 4:20 pm

420 with CNW — Activists Rally Governors on Marijuana Interstate Commerce Protections

America’s state-legal cannabis industry has been on a roll for the past few years. Cannabis companies have sold billions of dollars’ worth of products, created hundreds of thousands of new jobs and provided state coffers with millions of dollars in revenue. However, marijuana’s classification as a federally controlled substance has held the nascent but lucrative industry back, preventing cannabis companies from accessing crucial financial services, placing strict restrictions on marketing and advertising, and making interstate commerce nearly impossible. A group of cannabis activists is now urging businesses in the cannabis space to help them ask governors from key marijuana states…

MondayNov 29, 2021 9:30 am

RYAH Group Inc. (CSE: RYAH) Releases Overview of UK Cannabis Market

Market analysts place high hopes on the potential of the United Kingdom market Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence After three years of medical cannabis being legal in the United Kingdom, the country has a total of only three patients with a prescription in the entire public system, noted a recent blog from RYAH Group (CSE: RYAH). The article noted that many more patients receive cannabis-derived medications, including flower and cannabis oil,…

MondayNov 29, 2021 9:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Schedules November 29th for Q3 2021 Financials Release; November 30th for Earnings Discussion

RWB is set to release its Q3 financial results on November 29, 2021 A conference call will follow this release on November 30, 2021, at 5:00 PM ET to discuss these results, the company’s operations, upcoming events, and a Q&A session A replay of the call will be available for 90 days, starting three hours after the conclusion RWB is increasingly optimistic about its Q3 performance following growth in revenue from Q1 to Q2, along with strategic investments that would allow for Q3 growth Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) just announced that it will be releasing…

MondayNov 29, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs

InMed Pharmaceuticals released Q1 2022 financial results in which it reported a year-on-year increase in research and development expenses primarily due to increased activities related to INM-755 clinical trials The company’s cash, cash equivalents, and short-term investments also grew quarter over quarter from $7.4 million to $15.4 million Following the closing of BayMedica’s acquisition, the integrated teams are working together with a focus on launching selected rare cannabinoids, growing revenue, and expanding sales InMed has commenced Phase 2 clinical trial of INM-755 (cannabinol) cream for the treatment of a group of rare skin disorders Preclinical data of INM-088, the company’s…

MondayNov 29, 2021 4:20 am

420 with CNW — Pew Survey Finds Variations in Attitudes to Cannabis Legalization Within Parties

Historically, the left has been open to more liberal policies while the right has always espoused conservative beliefs. This has been especially evident in cannabis reform, and except for a recent Republican-led cannabis bill, the GOP and its followers haven’t been big fans of legalizing the adult use of cannabis. A new survey from the Pew Research Center shows that these disparities in political views not only vary between the two parties but also among party members themselves. Rather than two blocks with uniform political views, it’s more like a range of views that lean either right or left. However,…

WednesdayNov 24, 2021 4:20 pm

420 with CNW — Study Shows Mystical Experiences Are Intensified When Users Combine Psychedelics with Cannabis

New research has found that cannabis intensifies the experience of psychedelics by increasing the substances’ effects. The research was conducted by scientists at Imperial College London, with its findings being published in the “Psychopharmacology” journal. For their study, the researchers conducted an analysis of online surveys submitted by more than 300 people who gave descriptions of different aspects of their experiences with psychedelics and reported whether they had used marijuana together with these substances and, if so, the quantity they used. The researchers discovered that using cannabis with substances such as mescaline, ayahuasca, DMT, LSD or psilocybin simultaneously increased the…

WednesdayNov 24, 2021 8:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH(TM) Drug Delivery Technology Finding Multiple Medical Applications

Lexaria intends to undertake its most ambitious study yet – HYPER-H21-4 – as it pursues regulatory approval for DehydraTECH-CBD for potential use as a treatment for hypertension HYPER-H21-4 will build on successes witnessed in initial human hypertension studies The company, which has a fully funded R&D budget, recently announced new R&D programs covering multiple conditions, including dementia, diabetes, and rheumatoid disease Lexaria is committed to improving lives and lessening deaths through its patented DehydraTECH(TM) technology With a fully-funded research and development (“R&D”) budget, Lexaria Bioscience (NASDAQ: LEXX), a global leader in enhancing the speed, efficacy, bioavailability, and brain absorption of…

WednesdayNov 24, 2021 8:00 am

Marijuana Company of America Inc. (MCOA) Set to Launch VapeTV U.S. in a Three-Way Partnership

MCOA just signed an LOI with VapeTV UK and Jasleen Enterprises for the launch of VapeTV U.S. This new company is set to offer in-store advertising within retail vape stores It will capitalize on the growing CBD industry and the ever-increasing demand for in-store media advertising in the United States Marijuana Company of America (OTC: MCOA) has announced the signing of a non-binding letter of intent (“LOI”) that marks the beginning of the process to form a new in-store advertising brand named VapeTV US, Inc. (https://cnw.fm/jfcGM). VapeTV US will be the product of a three-way partnership among cDistro, Inc, a…

WednesdayNov 24, 2021 4:20 am

420 with CNW — Biden Signs Infrastructure Measure to Allow Studies on Cannabis from State-Legal Dispensaries

Earlier this week, President Joseph Biden signed a large-scale infrastructure outlining provisions that will permit scientists to conduct research on the cannabis that consumers buy from state-legal dispensaries. This bill encourages states that have enacted laws to legalize the herb to educate individuals on impaired driving. The bill also stipulates that the secretary of Health and Human Services and the attorney general will need to collaborate with the secretary of transportation to compile a public report within two years of the measure’s enactment that will include recommendations on permitting researchers to access retail-level cannabis to study impaired driving. The marijuana…

News and publishing service for cannabis related companies

Contact us: 512.354.7000